Literature DB >> 7538049

Reinduction of experimental autoimmune encephalomyelitis in mice.

J W Lindsey1, M Pappolla, L Steinman.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) in Lewis rats and some strains of mice is typically a monophasic disease, and recovered animals are resistant to reinduction of disease. We demonstrate that SJL mice remain susceptible to disease after recovery, and suffer a second episode of disease when reinjected with spinal cord homogenate in complete Freund's adjuvant. Reinduced disease occurs earlier after injection than the initial disease (mean onset 7.3 days compared with 14.5 days), and has comparable severity and incidence. The susceptibility to reinduced disease is present for at least 20 weeks after the initial injection. If the initial episode of EAE is elicited using a synthetic peptide of proteolipid protein, then reinjection of the same peptide causes reinduced disease. PL/J mice and PL/J x SJL F1 mice are also susceptible to reinduced disease which occurs with an accelerated onset and higher incidence than the initial disease. We conclude that SJL and PL/J mice have a defect in immunoregulation which causes them to be susceptible to recurrent episodes of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538049     DOI: 10.1006/cimm.1995.1074

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Clinical trial of immunostimulation with a biological response modifier in unexplained recurrent spontaneous abortion patients.

Authors:  K Katano; M Ogasawara; T Aoyama; Y Ozaki; S Kajiura; K Aoki
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

2.  Characteristics of initial and reinduced experimental autoimmune encephalomyelitis.

Authors:  J W Lindsey
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Authors:  E A Elliott; H I McFarland; S H Nye; R Cofiell; T M Wilson; J A Wilkins; S P Squinto; L A Matis; J P Mueller
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

4.  Determining disease intervention strategies using spatially resolved simulations.

Authors:  Mark Read; Paul S Andrews; Jon Timmis; Richard A Williams; Richard B Greaves; Huiming Sheng; Mark Coles; Vipin Kumar
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.